---
title: "Lupin: Quinapril 20 and 40 mg tablets — FDA announcement Dec 21, 2022 | Is It on Recall"
description: "Presence of nitrosamine impurity, N-Nitroso-Quinapril"
url: https://isitonrecall.com/recall/fdapress-cb338067c2d67f7c-lupin-quinapril-20-and-40-mg-tablets/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# Lupin: Quinapril 20 and 40 mg tablets — FDA announcement Dec 21, 2022

Reported terminated

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Dec 21, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Quinapril 20 and 40 mg tablets
- **Reason**: Presence of nitrosamine impurity, N-Nitroso-Quinapril
- **Classification**: Not supplied
- **Recalling firm**: Lupin Pharmaceuticals Inc.
- **Quantity**: Not supplied
- **Agency-reported status**: Terminated in FDA listing
- **Source record identifier**: cb338067c2d67f7c

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-four-lots-quinapril-tablets-due)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at (877) 538-8445 Monday – Friday 09:00 am to 05:00 pm EST. For reimbursement, please have the recalled lots returned to Inmar Rx Solutions, Inc.; the lot number can be found on the side of the bottle label.; Product \| Lot No \| Expiry \| NDC \| UPC \| Distribution Dates; Quinapril Tablets USP, 20mg \| G102929 \| 04/2023 \| 68180-558-09 (90’s) \| 368180558095 \| 03/15/2021 – 09/01/2022; Quinapril Tablets USP, 40mg \| G100533 G100534 G203071 \| 12/2022 12/2022 03/2024 \| 68180-554-09 (90’s) \| 368180554097 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

**FDA company announcement, table 1**

| Product | Lot No | Expiry | NDC | UPC | Distribution Dates |
| --- | --- | --- | --- | --- | --- |
| Quinapril Tablets USP, 20mg | G102929 | 04/2023 | 68180-558-09 (90’s) | 368180558095 | 03/15/2021 – 09/01/2022 |
| Quinapril Tablets USP, 40mg | G100533 G100534 G203071 | 12/2022 12/2022 03/2024 | 68180-554-09 (90’s) | 368180554097 | 03/15/2021 – 09/01/2022 |

Announcement retrieved Oct 1, 2026. [Official announcement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-four-lots-quinapril-tablets-due).

## Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Fda listing date**: Dec 21, 2022
- **Company announcement date**: Dec 21, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Patients taking, Quinapril Tablets USP, 20mg, and 40mg are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at (877) 538-8445 Monday – Friday 09:00 am to 05:00 pm EST. For reimbursement, please have the recalled lots returned to Inmar Rx Solutions, Inc.; the lot number can be found on the side of the bottle label.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-four-lots-quinapril-tablets-due)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Lupin Pharmaceuticals Inc. records](https://isitonrecall.com/brand/lupin-pharmaceuticals-inc/)